AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients
Phase 2
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Drug: AZD9668Drug: Placebo
- First Posted Date
- 2008-06-23
- Last Posted Date
- 2012-01-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 18
- Registration Number
- NCT00703391
- Locations
- 🇩🇪
Research Site, Berlin, Germany
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
Phase 2
Completed
- Conditions
- GERDAcid Reflux DiseaseHeartburnRegurgitation
- Interventions
- First Posted Date
- 2008-06-23
- Last Posted Date
- 2011-06-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 478
- Registration Number
- NCT00703534
- Locations
- 🇺🇸
Research Site, West End, Wisconsin, United States
Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2009-07-16
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 63
- Registration Number
- NCT00702676
- Locations
- 🇺🇸
Research Site, Baltimore, Maryland, United States
Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans
Phase 4
Completed
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2012-11-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 311
- Registration Number
- NCT00702325
- Locations
- 🇺🇸
Research Site, Milwaukee, Wisconsin, United States
National Survey on Dyslipidemic Patients
Completed
- Conditions
- Dyslipidemia
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 3655
- Registration Number
- NCT00701402
- Locations
- 🇫🇷
Research Site, Yquelon, France
Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056
Phase 1
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: AZD9056Drug: Placebo
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2010-12-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 12
- Registration Number
- NCT00700986
- Locations
- 🇬🇧
Research Site, Nottingham, Nottinghamshire, United Kingdom
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2015-04-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 80
- Registration Number
- NCT00701935
- Locations
- 🇨🇦
Research Site, Quebec, Canada
National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups
Completed
- Conditions
- Coronary PatientsHeart Failure
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1650
- Registration Number
- NCT00699959
- Locations
- 🇫🇷
Research Site, Wattrelos Cedex, France
Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients
Completed
- Conditions
- ComplianceGastroprotector TherapyRisk Factors
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2010-12-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2000
- Registration Number
- NCT00699725
- Locations
- 🇪🇸
Research Site, Zaragoza, Spain
Observational Study on Costs and Caregiver Burden in Alzheimer's Disease
Completed
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2400
- Registration Number
- NCT00698165
- Locations
- 🇬🇧
Research Site, Uckfield, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath